Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Action to Control Cardiovascular Risk in Diabetes (ACCORD)

NCT00000620 is registered in ClinicalTrials.gov with National Heart, Lung, and Blood Institute (NHLBI) as lead sponsor.

NCT NCT00000620
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00000620 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Phase
Phase 3
Overall status
Completed
Start date
September 30, 1999
Completion date
December 31, 2012
Enrollment
10,251 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis, cardiovascular diseases, coronary disease, diabetes mellitus, diabetes mellitus, type 2, hypercholesterolemia, hypertension